Global Taurine and Derivatives Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Taurine and Derivatives market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
This report is a detailed and comprehensive analysis for global Taurine and Derivatives market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Taurine and Derivatives market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Taurine and Derivatives market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Taurine and Derivatives market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Taurine and Derivatives market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Taurine and Derivatives
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Taurine and Derivatives market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yongan Pharmaceutical, Grand Pharma, Jiangyin Huachang, Yuanyang Pharmaceutical, Taisho Pharmaceutical, Zhejiang NHU Co., Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Taurine and Derivatives market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Taurine and Derivatives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Taurine and Derivatives, with price, sales quantity, revenue, and global market share of Taurine and Derivatives from 2020 to 2025.
Chapter 3, the Taurine and Derivatives competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Taurine and Derivatives breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Taurine and Derivatives market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Taurine and Derivatives.
Chapter 14 and 15, to describe Taurine and Derivatives sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Taurine, or 2-aminoethanesulfonic acid, is a non-proteinogenic naturally occurred amino sulfonic acid that is widely distributed in animal tissues.[1] It is a major constituent of bile and can be found in the large intestine, and accounts for up to 0.1% of total human body weight.
This report is a detailed and comprehensive analysis for global Taurine and Derivatives market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Taurine and Derivatives market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Taurine and Derivatives market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Taurine and Derivatives market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Taurine and Derivatives market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Taurine and Derivatives
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Taurine and Derivatives market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yongan Pharmaceutical, Grand Pharma, Jiangyin Huachang, Yuanyang Pharmaceutical, Taisho Pharmaceutical, Zhejiang NHU Co., Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Taurine and Derivatives market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Taurine
- Taurine Derivatives
- Beverages
- Health Products
- Pet Food
- Others
- Yongan Pharmaceutical
- Grand Pharma
- Jiangyin Huachang
- Yuanyang Pharmaceutical
- Taisho Pharmaceutical
- Zhejiang NHU Co., Ltd
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Taurine and Derivatives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Taurine and Derivatives, with price, sales quantity, revenue, and global market share of Taurine and Derivatives from 2020 to 2025.
Chapter 3, the Taurine and Derivatives competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Taurine and Derivatives breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Taurine and Derivatives market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Taurine and Derivatives.
Chapter 14 and 15, to describe Taurine and Derivatives sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Taurine and Derivatives Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Taurine
1.3.3 Taurine Derivatives
1.4 Market Analysis by Application
1.4.1 Overview: Global Taurine and Derivatives Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Beverages
1.4.3 Health Products
1.4.4 Pet Food
1.4.5 Others
1.5 Global Taurine and Derivatives Market Size & Forecast
1.5.1 Global Taurine and Derivatives Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Taurine and Derivatives Sales Quantity (2020-2031)
1.5.3 Global Taurine and Derivatives Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Yongan Pharmaceutical
2.1.1 Yongan Pharmaceutical Details
2.1.2 Yongan Pharmaceutical Major Business
2.1.3 Yongan Pharmaceutical Taurine and Derivatives Product and Services
2.1.4 Yongan Pharmaceutical Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Yongan Pharmaceutical Recent Developments/Updates
2.2 Grand Pharma
2.2.1 Grand Pharma Details
2.2.2 Grand Pharma Major Business
2.2.3 Grand Pharma Taurine and Derivatives Product and Services
2.2.4 Grand Pharma Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Grand Pharma Recent Developments/Updates
2.3 Jiangyin Huachang
2.3.1 Jiangyin Huachang Details
2.3.2 Jiangyin Huachang Major Business
2.3.3 Jiangyin Huachang Taurine and Derivatives Product and Services
2.3.4 Jiangyin Huachang Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Jiangyin Huachang Recent Developments/Updates
2.4 Yuanyang Pharmaceutical
2.4.1 Yuanyang Pharmaceutical Details
2.4.2 Yuanyang Pharmaceutical Major Business
2.4.3 Yuanyang Pharmaceutical Taurine and Derivatives Product and Services
2.4.4 Yuanyang Pharmaceutical Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Yuanyang Pharmaceutical Recent Developments/Updates
2.5 Taisho Pharmaceutical
2.5.1 Taisho Pharmaceutical Details
2.5.2 Taisho Pharmaceutical Major Business
2.5.3 Taisho Pharmaceutical Taurine and Derivatives Product and Services
2.5.4 Taisho Pharmaceutical Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Taisho Pharmaceutical Recent Developments/Updates
2.6 Zhejiang NHU Co., Ltd
2.6.1 Zhejiang NHU Co., Ltd Details
2.6.2 Zhejiang NHU Co., Ltd Major Business
2.6.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Product and Services
2.6.4 Zhejiang NHU Co., Ltd Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Zhejiang NHU Co., Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TAURINE AND DERIVATIVES BY MANUFACTURER
3.1 Global Taurine and Derivatives Sales Quantity by Manufacturer (2020-2025)
3.2 Global Taurine and Derivatives Revenue by Manufacturer (2020-2025)
3.3 Global Taurine and Derivatives Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Taurine and Derivatives by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Taurine and Derivatives Manufacturer Market Share in 2024
3.4.3 Top 6 Taurine and Derivatives Manufacturer Market Share in 2024
3.5 Taurine and Derivatives Market: Overall Company Footprint Analysis
3.5.1 Taurine and Derivatives Market: Region Footprint
3.5.2 Taurine and Derivatives Market: Company Product Type Footprint
3.5.3 Taurine and Derivatives Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Taurine and Derivatives Market Size by Region
4.1.1 Global Taurine and Derivatives Sales Quantity by Region (2020-2031)
4.1.2 Global Taurine and Derivatives Consumption Value by Region (2020-2031)
4.1.3 Global Taurine and Derivatives Average Price by Region (2020-2031)
4.2 North America Taurine and Derivatives Consumption Value (2020-2031)
4.3 Europe Taurine and Derivatives Consumption Value (2020-2031)
4.4 Asia-Pacific Taurine and Derivatives Consumption Value (2020-2031)
4.5 South America Taurine and Derivatives Consumption Value (2020-2031)
4.6 Middle East & Africa Taurine and Derivatives Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Taurine and Derivatives Sales Quantity by Type (2020-2031)
5.2 Global Taurine and Derivatives Consumption Value by Type (2020-2031)
5.3 Global Taurine and Derivatives Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Taurine and Derivatives Sales Quantity by Application (2020-2031)
6.2 Global Taurine and Derivatives Consumption Value by Application (2020-2031)
6.3 Global Taurine and Derivatives Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Taurine and Derivatives Sales Quantity by Type (2020-2031)
7.2 North America Taurine and Derivatives Sales Quantity by Application (2020-2031)
7.3 North America Taurine and Derivatives Market Size by Country
7.3.1 North America Taurine and Derivatives Sales Quantity by Country (2020-2031)
7.3.2 North America Taurine and Derivatives Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Taurine and Derivatives Sales Quantity by Type (2020-2031)
8.2 Europe Taurine and Derivatives Sales Quantity by Application (2020-2031)
8.3 Europe Taurine and Derivatives Market Size by Country
8.3.1 Europe Taurine and Derivatives Sales Quantity by Country (2020-2031)
8.3.2 Europe Taurine and Derivatives Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Taurine and Derivatives Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Taurine and Derivatives Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Taurine and Derivatives Market Size by Region
9.3.1 Asia-Pacific Taurine and Derivatives Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Taurine and Derivatives Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Taurine and Derivatives Sales Quantity by Type (2020-2031)
10.2 South America Taurine and Derivatives Sales Quantity by Application (2020-2031)
10.3 South America Taurine and Derivatives Market Size by Country
10.3.1 South America Taurine and Derivatives Sales Quantity by Country (2020-2031)
10.3.2 South America Taurine and Derivatives Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Taurine and Derivatives Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Taurine and Derivatives Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Taurine and Derivatives Market Size by Country
11.3.1 Middle East & Africa Taurine and Derivatives Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Taurine and Derivatives Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Taurine and Derivatives Market Drivers
12.2 Taurine and Derivatives Market Restraints
12.3 Taurine and Derivatives Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Taurine and Derivatives and Key Manufacturers
13.2 Manufacturing Costs Percentage of Taurine and Derivatives
13.3 Taurine and Derivatives Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Taurine and Derivatives Typical Distributors
14.3 Taurine and Derivatives Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Taurine and Derivatives Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Taurine
1.3.3 Taurine Derivatives
1.4 Market Analysis by Application
1.4.1 Overview: Global Taurine and Derivatives Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Beverages
1.4.3 Health Products
1.4.4 Pet Food
1.4.5 Others
1.5 Global Taurine and Derivatives Market Size & Forecast
1.5.1 Global Taurine and Derivatives Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Taurine and Derivatives Sales Quantity (2020-2031)
1.5.3 Global Taurine and Derivatives Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Yongan Pharmaceutical
2.1.1 Yongan Pharmaceutical Details
2.1.2 Yongan Pharmaceutical Major Business
2.1.3 Yongan Pharmaceutical Taurine and Derivatives Product and Services
2.1.4 Yongan Pharmaceutical Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Yongan Pharmaceutical Recent Developments/Updates
2.2 Grand Pharma
2.2.1 Grand Pharma Details
2.2.2 Grand Pharma Major Business
2.2.3 Grand Pharma Taurine and Derivatives Product and Services
2.2.4 Grand Pharma Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Grand Pharma Recent Developments/Updates
2.3 Jiangyin Huachang
2.3.1 Jiangyin Huachang Details
2.3.2 Jiangyin Huachang Major Business
2.3.3 Jiangyin Huachang Taurine and Derivatives Product and Services
2.3.4 Jiangyin Huachang Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Jiangyin Huachang Recent Developments/Updates
2.4 Yuanyang Pharmaceutical
2.4.1 Yuanyang Pharmaceutical Details
2.4.2 Yuanyang Pharmaceutical Major Business
2.4.3 Yuanyang Pharmaceutical Taurine and Derivatives Product and Services
2.4.4 Yuanyang Pharmaceutical Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Yuanyang Pharmaceutical Recent Developments/Updates
2.5 Taisho Pharmaceutical
2.5.1 Taisho Pharmaceutical Details
2.5.2 Taisho Pharmaceutical Major Business
2.5.3 Taisho Pharmaceutical Taurine and Derivatives Product and Services
2.5.4 Taisho Pharmaceutical Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Taisho Pharmaceutical Recent Developments/Updates
2.6 Zhejiang NHU Co., Ltd
2.6.1 Zhejiang NHU Co., Ltd Details
2.6.2 Zhejiang NHU Co., Ltd Major Business
2.6.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Product and Services
2.6.4 Zhejiang NHU Co., Ltd Taurine and Derivatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Zhejiang NHU Co., Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TAURINE AND DERIVATIVES BY MANUFACTURER
3.1 Global Taurine and Derivatives Sales Quantity by Manufacturer (2020-2025)
3.2 Global Taurine and Derivatives Revenue by Manufacturer (2020-2025)
3.3 Global Taurine and Derivatives Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Taurine and Derivatives by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Taurine and Derivatives Manufacturer Market Share in 2024
3.4.3 Top 6 Taurine and Derivatives Manufacturer Market Share in 2024
3.5 Taurine and Derivatives Market: Overall Company Footprint Analysis
3.5.1 Taurine and Derivatives Market: Region Footprint
3.5.2 Taurine and Derivatives Market: Company Product Type Footprint
3.5.3 Taurine and Derivatives Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Taurine and Derivatives Market Size by Region
4.1.1 Global Taurine and Derivatives Sales Quantity by Region (2020-2031)
4.1.2 Global Taurine and Derivatives Consumption Value by Region (2020-2031)
4.1.3 Global Taurine and Derivatives Average Price by Region (2020-2031)
4.2 North America Taurine and Derivatives Consumption Value (2020-2031)
4.3 Europe Taurine and Derivatives Consumption Value (2020-2031)
4.4 Asia-Pacific Taurine and Derivatives Consumption Value (2020-2031)
4.5 South America Taurine and Derivatives Consumption Value (2020-2031)
4.6 Middle East & Africa Taurine and Derivatives Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Taurine and Derivatives Sales Quantity by Type (2020-2031)
5.2 Global Taurine and Derivatives Consumption Value by Type (2020-2031)
5.3 Global Taurine and Derivatives Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Taurine and Derivatives Sales Quantity by Application (2020-2031)
6.2 Global Taurine and Derivatives Consumption Value by Application (2020-2031)
6.3 Global Taurine and Derivatives Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Taurine and Derivatives Sales Quantity by Type (2020-2031)
7.2 North America Taurine and Derivatives Sales Quantity by Application (2020-2031)
7.3 North America Taurine and Derivatives Market Size by Country
7.3.1 North America Taurine and Derivatives Sales Quantity by Country (2020-2031)
7.3.2 North America Taurine and Derivatives Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Taurine and Derivatives Sales Quantity by Type (2020-2031)
8.2 Europe Taurine and Derivatives Sales Quantity by Application (2020-2031)
8.3 Europe Taurine and Derivatives Market Size by Country
8.3.1 Europe Taurine and Derivatives Sales Quantity by Country (2020-2031)
8.3.2 Europe Taurine and Derivatives Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Taurine and Derivatives Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Taurine and Derivatives Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Taurine and Derivatives Market Size by Region
9.3.1 Asia-Pacific Taurine and Derivatives Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Taurine and Derivatives Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Taurine and Derivatives Sales Quantity by Type (2020-2031)
10.2 South America Taurine and Derivatives Sales Quantity by Application (2020-2031)
10.3 South America Taurine and Derivatives Market Size by Country
10.3.1 South America Taurine and Derivatives Sales Quantity by Country (2020-2031)
10.3.2 South America Taurine and Derivatives Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Taurine and Derivatives Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Taurine and Derivatives Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Taurine and Derivatives Market Size by Country
11.3.1 Middle East & Africa Taurine and Derivatives Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Taurine and Derivatives Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Taurine and Derivatives Market Drivers
12.2 Taurine and Derivatives Market Restraints
12.3 Taurine and Derivatives Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Taurine and Derivatives and Key Manufacturers
13.2 Manufacturing Costs Percentage of Taurine and Derivatives
13.3 Taurine and Derivatives Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Taurine and Derivatives Typical Distributors
14.3 Taurine and Derivatives Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Taurine and Derivatives Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Taurine and Derivatives Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Yongan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Yongan Pharmaceutical Major Business
Table 5. Yongan Pharmaceutical Taurine and Derivatives Product and Services
Table 6. Yongan Pharmaceutical Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Yongan Pharmaceutical Recent Developments/Updates
Table 8. Grand Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Grand Pharma Major Business
Table 10. Grand Pharma Taurine and Derivatives Product and Services
Table 11. Grand Pharma Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Grand Pharma Recent Developments/Updates
Table 13. Jiangyin Huachang Basic Information, Manufacturing Base and Competitors
Table 14. Jiangyin Huachang Major Business
Table 15. Jiangyin Huachang Taurine and Derivatives Product and Services
Table 16. Jiangyin Huachang Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Jiangyin Huachang Recent Developments/Updates
Table 18. Yuanyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Yuanyang Pharmaceutical Major Business
Table 20. Yuanyang Pharmaceutical Taurine and Derivatives Product and Services
Table 21. Yuanyang Pharmaceutical Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Yuanyang Pharmaceutical Recent Developments/Updates
Table 23. Taisho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Taisho Pharmaceutical Major Business
Table 25. Taisho Pharmaceutical Taurine and Derivatives Product and Services
Table 26. Taisho Pharmaceutical Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Taisho Pharmaceutical Recent Developments/Updates
Table 28. Zhejiang NHU Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Zhejiang NHU Co., Ltd Major Business
Table 30. Zhejiang NHU Co., Ltd Taurine and Derivatives Product and Services
Table 31. Zhejiang NHU Co., Ltd Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Zhejiang NHU Co., Ltd Recent Developments/Updates
Table 33. Global Taurine and Derivatives Sales Quantity by Manufacturer (2020-2025) & (Tons)
Table 34. Global Taurine and Derivatives Revenue by Manufacturer (2020-2025) & (USD Million)
Table 35. Global Taurine and Derivatives Average Price by Manufacturer (2020-2025) & (US$/Ton)
Table 36. Market Position of Manufacturers in Taurine and Derivatives, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 37. Head Office and Taurine and Derivatives Production Site of Key Manufacturer
Table 38. Taurine and Derivatives Market: Company Product Type Footprint
Table 39. Taurine and Derivatives Market: Company Product Application Footprint
Table 40. Taurine and Derivatives New Market Entrants and Barriers to Market Entry
Table 41. Taurine and Derivatives Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Taurine and Derivatives Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 43. Global Taurine and Derivatives Sales Quantity by Region (2020-2025) & (Tons)
Table 44. Global Taurine and Derivatives Sales Quantity by Region (2026-2031) & (Tons)
Table 45. Global Taurine and Derivatives Consumption Value by Region (2020-2025) & (USD Million)
Table 46. Global Taurine and Derivatives Consumption Value by Region (2026-2031) & (USD Million)
Table 47. Global Taurine and Derivatives Average Price by Region (2020-2025) & (US$/Ton)
Table 48. Global Taurine and Derivatives Average Price by Region (2026-2031) & (US$/Ton)
Table 49. Global Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 50. Global Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 51. Global Taurine and Derivatives Consumption Value by Type (2020-2025) & (USD Million)
Table 52. Global Taurine and Derivatives Consumption Value by Type (2026-2031) & (USD Million)
Table 53. Global Taurine and Derivatives Average Price by Type (2020-2025) & (US$/Ton)
Table 54. Global Taurine and Derivatives Average Price by Type (2026-2031) & (US$/Ton)
Table 55. Global Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 56. Global Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 57. Global Taurine and Derivatives Consumption Value by Application (2020-2025) & (USD Million)
Table 58. Global Taurine and Derivatives Consumption Value by Application (2026-2031) & (USD Million)
Table 59. Global Taurine and Derivatives Average Price by Application (2020-2025) & (US$/Ton)
Table 60. Global Taurine and Derivatives Average Price by Application (2026-2031) & (US$/Ton)
Table 61. North America Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 62. North America Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 63. North America Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 64. North America Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 65. North America Taurine and Derivatives Sales Quantity by Country (2020-2025) & (Tons)
Table 66. North America Taurine and Derivatives Sales Quantity by Country (2026-2031) & (Tons)
Table 67. North America Taurine and Derivatives Consumption Value by Country (2020-2025) & (USD Million)
Table 68. North America Taurine and Derivatives Consumption Value by Country (2026-2031) & (USD Million)
Table 69. Europe Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 70. Europe Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 71. Europe Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 72. Europe Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 73. Europe Taurine and Derivatives Sales Quantity by Country (2020-2025) & (Tons)
Table 74. Europe Taurine and Derivatives Sales Quantity by Country (2026-2031) & (Tons)
Table 75. Europe Taurine and Derivatives Consumption Value by Country (2020-2025) & (USD Million)
Table 76. Europe Taurine and Derivatives Consumption Value by Country (2026-2031) & (USD Million)
Table 77. Asia-Pacific Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 78. Asia-Pacific Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 79. Asia-Pacific Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 80. Asia-Pacific Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 81. Asia-Pacific Taurine and Derivatives Sales Quantity by Region (2020-2025) & (Tons)
Table 82. Asia-Pacific Taurine and Derivatives Sales Quantity by Region (2026-2031) & (Tons)
Table 83. Asia-Pacific Taurine and Derivatives Consumption Value by Region (2020-2025) & (USD Million)
Table 84. Asia-Pacific Taurine and Derivatives Consumption Value by Region (2026-2031) & (USD Million)
Table 85. South America Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 86. South America Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 87. South America Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 88. South America Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 89. South America Taurine and Derivatives Sales Quantity by Country (2020-2025) & (Tons)
Table 90. South America Taurine and Derivatives Sales Quantity by Country (2026-2031) & (Tons)
Table 91. South America Taurine and Derivatives Consumption Value by Country (2020-2025) & (USD Million)
Table 92. South America Taurine and Derivatives Consumption Value by Country (2026-2031) & (USD Million)
Table 93. Middle East & Africa Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 94. Middle East & Africa Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 95. Middle East & Africa Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 96. Middle East & Africa Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 97. Middle East & Africa Taurine and Derivatives Sales Quantity by Country (2020-2025) & (Tons)
Table 98. Middle East & Africa Taurine and Derivatives Sales Quantity by Country (2026-2031) & (Tons)
Table 99. Middle East & Africa Taurine and Derivatives Consumption Value by Country (2020-2025) & (USD Million)
Table 100. Middle East & Africa Taurine and Derivatives Consumption Value by Country (2026-2031) & (USD Million)
Table 101. Taurine and Derivatives Raw Material
Table 102. Key Manufacturers of Taurine and Derivatives Raw Materials
Table 103. Taurine and Derivatives Typical Distributors
Table 104. Taurine and Derivatives Typical Customers
Table 1. Global Taurine and Derivatives Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Taurine and Derivatives Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Yongan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Yongan Pharmaceutical Major Business
Table 5. Yongan Pharmaceutical Taurine and Derivatives Product and Services
Table 6. Yongan Pharmaceutical Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Yongan Pharmaceutical Recent Developments/Updates
Table 8. Grand Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Grand Pharma Major Business
Table 10. Grand Pharma Taurine and Derivatives Product and Services
Table 11. Grand Pharma Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Grand Pharma Recent Developments/Updates
Table 13. Jiangyin Huachang Basic Information, Manufacturing Base and Competitors
Table 14. Jiangyin Huachang Major Business
Table 15. Jiangyin Huachang Taurine and Derivatives Product and Services
Table 16. Jiangyin Huachang Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Jiangyin Huachang Recent Developments/Updates
Table 18. Yuanyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Yuanyang Pharmaceutical Major Business
Table 20. Yuanyang Pharmaceutical Taurine and Derivatives Product and Services
Table 21. Yuanyang Pharmaceutical Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Yuanyang Pharmaceutical Recent Developments/Updates
Table 23. Taisho Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Taisho Pharmaceutical Major Business
Table 25. Taisho Pharmaceutical Taurine and Derivatives Product and Services
Table 26. Taisho Pharmaceutical Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Taisho Pharmaceutical Recent Developments/Updates
Table 28. Zhejiang NHU Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 29. Zhejiang NHU Co., Ltd Major Business
Table 30. Zhejiang NHU Co., Ltd Taurine and Derivatives Product and Services
Table 31. Zhejiang NHU Co., Ltd Taurine and Derivatives Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Zhejiang NHU Co., Ltd Recent Developments/Updates
Table 33. Global Taurine and Derivatives Sales Quantity by Manufacturer (2020-2025) & (Tons)
Table 34. Global Taurine and Derivatives Revenue by Manufacturer (2020-2025) & (USD Million)
Table 35. Global Taurine and Derivatives Average Price by Manufacturer (2020-2025) & (US$/Ton)
Table 36. Market Position of Manufacturers in Taurine and Derivatives, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 37. Head Office and Taurine and Derivatives Production Site of Key Manufacturer
Table 38. Taurine and Derivatives Market: Company Product Type Footprint
Table 39. Taurine and Derivatives Market: Company Product Application Footprint
Table 40. Taurine and Derivatives New Market Entrants and Barriers to Market Entry
Table 41. Taurine and Derivatives Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Taurine and Derivatives Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 43. Global Taurine and Derivatives Sales Quantity by Region (2020-2025) & (Tons)
Table 44. Global Taurine and Derivatives Sales Quantity by Region (2026-2031) & (Tons)
Table 45. Global Taurine and Derivatives Consumption Value by Region (2020-2025) & (USD Million)
Table 46. Global Taurine and Derivatives Consumption Value by Region (2026-2031) & (USD Million)
Table 47. Global Taurine and Derivatives Average Price by Region (2020-2025) & (US$/Ton)
Table 48. Global Taurine and Derivatives Average Price by Region (2026-2031) & (US$/Ton)
Table 49. Global Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 50. Global Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 51. Global Taurine and Derivatives Consumption Value by Type (2020-2025) & (USD Million)
Table 52. Global Taurine and Derivatives Consumption Value by Type (2026-2031) & (USD Million)
Table 53. Global Taurine and Derivatives Average Price by Type (2020-2025) & (US$/Ton)
Table 54. Global Taurine and Derivatives Average Price by Type (2026-2031) & (US$/Ton)
Table 55. Global Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 56. Global Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 57. Global Taurine and Derivatives Consumption Value by Application (2020-2025) & (USD Million)
Table 58. Global Taurine and Derivatives Consumption Value by Application (2026-2031) & (USD Million)
Table 59. Global Taurine and Derivatives Average Price by Application (2020-2025) & (US$/Ton)
Table 60. Global Taurine and Derivatives Average Price by Application (2026-2031) & (US$/Ton)
Table 61. North America Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 62. North America Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 63. North America Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 64. North America Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 65. North America Taurine and Derivatives Sales Quantity by Country (2020-2025) & (Tons)
Table 66. North America Taurine and Derivatives Sales Quantity by Country (2026-2031) & (Tons)
Table 67. North America Taurine and Derivatives Consumption Value by Country (2020-2025) & (USD Million)
Table 68. North America Taurine and Derivatives Consumption Value by Country (2026-2031) & (USD Million)
Table 69. Europe Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 70. Europe Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 71. Europe Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 72. Europe Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 73. Europe Taurine and Derivatives Sales Quantity by Country (2020-2025) & (Tons)
Table 74. Europe Taurine and Derivatives Sales Quantity by Country (2026-2031) & (Tons)
Table 75. Europe Taurine and Derivatives Consumption Value by Country (2020-2025) & (USD Million)
Table 76. Europe Taurine and Derivatives Consumption Value by Country (2026-2031) & (USD Million)
Table 77. Asia-Pacific Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 78. Asia-Pacific Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 79. Asia-Pacific Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 80. Asia-Pacific Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 81. Asia-Pacific Taurine and Derivatives Sales Quantity by Region (2020-2025) & (Tons)
Table 82. Asia-Pacific Taurine and Derivatives Sales Quantity by Region (2026-2031) & (Tons)
Table 83. Asia-Pacific Taurine and Derivatives Consumption Value by Region (2020-2025) & (USD Million)
Table 84. Asia-Pacific Taurine and Derivatives Consumption Value by Region (2026-2031) & (USD Million)
Table 85. South America Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 86. South America Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 87. South America Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 88. South America Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 89. South America Taurine and Derivatives Sales Quantity by Country (2020-2025) & (Tons)
Table 90. South America Taurine and Derivatives Sales Quantity by Country (2026-2031) & (Tons)
Table 91. South America Taurine and Derivatives Consumption Value by Country (2020-2025) & (USD Million)
Table 92. South America Taurine and Derivatives Consumption Value by Country (2026-2031) & (USD Million)
Table 93. Middle East & Africa Taurine and Derivatives Sales Quantity by Type (2020-2025) & (Tons)
Table 94. Middle East & Africa Taurine and Derivatives Sales Quantity by Type (2026-2031) & (Tons)
Table 95. Middle East & Africa Taurine and Derivatives Sales Quantity by Application (2020-2025) & (Tons)
Table 96. Middle East & Africa Taurine and Derivatives Sales Quantity by Application (2026-2031) & (Tons)
Table 97. Middle East & Africa Taurine and Derivatives Sales Quantity by Country (2020-2025) & (Tons)
Table 98. Middle East & Africa Taurine and Derivatives Sales Quantity by Country (2026-2031) & (Tons)
Table 99. Middle East & Africa Taurine and Derivatives Consumption Value by Country (2020-2025) & (USD Million)
Table 100. Middle East & Africa Taurine and Derivatives Consumption Value by Country (2026-2031) & (USD Million)
Table 101. Taurine and Derivatives Raw Material
Table 102. Key Manufacturers of Taurine and Derivatives Raw Materials
Table 103. Taurine and Derivatives Typical Distributors
Table 104. Taurine and Derivatives Typical Customers
LIST OF FIGURES
Figure 1. Taurine and Derivatives Picture
Figure 2. Global Taurine and Derivatives Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Taurine and Derivatives Revenue Market Share by Type in 2024
Figure 4. Taurine Examples
Figure 5. Taurine Derivatives Examples
Figure 6. Global Taurine and Derivatives Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Taurine and Derivatives Revenue Market Share by Application in 2024
Figure 8. Beverages Examples
Figure 9. Health Products Examples
Figure 10. Pet Food Examples
Figure 11. Others Examples
Figure 12. Global Taurine and Derivatives Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Taurine and Derivatives Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Taurine and Derivatives Sales Quantity (2020-2031) & (Tons)
Figure 15. Global Taurine and Derivatives Price (2020-2031) & (US$/Ton)
Figure 16. Global Taurine and Derivatives Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Taurine and Derivatives Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Taurine and Derivatives by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Taurine and Derivatives Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Taurine and Derivatives Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Taurine and Derivatives Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Taurine and Derivatives Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Taurine and Derivatives Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Taurine and Derivatives Average Price by Type (2020-2031) & (US$/Ton)
Figure 31. Global Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Taurine and Derivatives Revenue Market Share by Application (2020-2031)
Figure 33. Global Taurine and Derivatives Average Price by Application (2020-2031) & (US$/Ton)
Figure 34. North America Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Taurine and Derivatives Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Taurine and Derivatives Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Taurine and Derivatives Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Taurine and Derivatives Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 46. France Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Taurine and Derivatives Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Taurine and Derivatives Consumption Value Market Share by Region (2020-2031)
Figure 54. China Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 57. India Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Taurine and Derivatives Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Taurine and Derivatives Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Taurine and Derivatives Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Taurine and Derivatives Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 74. Taurine and Derivatives Market Drivers
Figure 75. Taurine and Derivatives Market Restraints
Figure 76. Taurine and Derivatives Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Taurine and Derivatives in 2024
Figure 79. Manufacturing Process Analysis of Taurine and Derivatives
Figure 80. Taurine and Derivatives Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Taurine and Derivatives Picture
Figure 2. Global Taurine and Derivatives Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Taurine and Derivatives Revenue Market Share by Type in 2024
Figure 4. Taurine Examples
Figure 5. Taurine Derivatives Examples
Figure 6. Global Taurine and Derivatives Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Taurine and Derivatives Revenue Market Share by Application in 2024
Figure 8. Beverages Examples
Figure 9. Health Products Examples
Figure 10. Pet Food Examples
Figure 11. Others Examples
Figure 12. Global Taurine and Derivatives Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Taurine and Derivatives Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Taurine and Derivatives Sales Quantity (2020-2031) & (Tons)
Figure 15. Global Taurine and Derivatives Price (2020-2031) & (US$/Ton)
Figure 16. Global Taurine and Derivatives Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Taurine and Derivatives Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Taurine and Derivatives by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Taurine and Derivatives Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Taurine and Derivatives Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Taurine and Derivatives Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Taurine and Derivatives Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Taurine and Derivatives Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Taurine and Derivatives Average Price by Type (2020-2031) & (US$/Ton)
Figure 31. Global Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Taurine and Derivatives Revenue Market Share by Application (2020-2031)
Figure 33. Global Taurine and Derivatives Average Price by Application (2020-2031) & (US$/Ton)
Figure 34. North America Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Taurine and Derivatives Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Taurine and Derivatives Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Taurine and Derivatives Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Taurine and Derivatives Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 46. France Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Taurine and Derivatives Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Taurine and Derivatives Consumption Value Market Share by Region (2020-2031)
Figure 54. China Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 57. India Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Taurine and Derivatives Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Taurine and Derivatives Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Taurine and Derivatives Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Taurine and Derivatives Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Taurine and Derivatives Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Taurine and Derivatives Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Taurine and Derivatives Consumption Value (2020-2031) & (USD Million)
Figure 74. Taurine and Derivatives Market Drivers
Figure 75. Taurine and Derivatives Market Restraints
Figure 76. Taurine and Derivatives Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Taurine and Derivatives in 2024
Figure 79. Manufacturing Process Analysis of Taurine and Derivatives
Figure 80. Taurine and Derivatives Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
